RO5217790

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5217790, covering 2016-08-15 to 2016-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection [Phase 2]

See pricing